Trial Profile
Safety and efficacy of long-term treatment with Orlistat in Japanese subjects with excessive visceral fat accumulation and without metabolic diseases.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2018
Price :
$35
*
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Adverse reactions
- 29 Nov 2018 New trial record
- 01 Nov 2018 Results published in the Advances in Therapy